Logo main
  • PROMOTE YOUR VENTURE
    • Startup listings
    • IP & Tech listings
  • GET HELP
    • Search questions
    • Post projects
    • Search expert directory
  • RESOURCES
    • Document Center
    • Search for patents
    • Expert articles / posts
  • NEWS & EVENTS
    • Tech & IP News
  • My Account
  • Sign in
  • FOR PROFESSIONALS
  • Icon jp

Patents

68,020 found
SEE ALL IP TYPES
PATENTFIELD SEARCH
UPLOAD IP
Granted

Application security

Application security (short: AppSec) encompasses measures taken throughout the code's life-cycle to prevent gaps in the security policy of an application or the underlying system (vulnerabilities) ...

Granted

Human fusion partner cell l...

Human fusion partner cell lines

Granted

Minimal access procedure

Minimal access procedure

Granted

Network attack inhibition

Network attack inhibition

Pending

Blood-brain barrier

The blood–brain barrier (BBB) is a highly selective permeability barrier that separates the circulating blood from the brain extracellular fluid (BECF) in the central nervous system (CNS). The bloo...

Pending

Direct methanol fuel cell

Direct-methanol fuel cells or DMFCs are a subcategory of proton-exchange fuel cells in which methanol is used as the fuel. Their main advantage is the ease of transport of methanol, an energy-dense...

Pending

Small molecules

In molecular biology and pharmacology, a small molecule is a low molecular weight (<900 daltons[1]) organic compound that may help regulate a biological process, with a size on the order of 10−9 m....

Pending

Ligand

In biochemistry and pharmacology, a ligand is a substance (usually a small molecule) that forms a complex with a biomolecule to serve a biological purpose. In protein-ligand binding, the ligand is ...

Pending

Nucleic acid arrays

Nucleic acid arrays

Pending

Cancer/Neurodegenerative di...

Cancer/Neurodegenerative disorders

Pending

LMNA gene

Lamin A/C also known as LMNA is a protein that in humans is encoded by the LMNA gene.[1][2] Lamin A/C belongs to the lamin family of proteins. The nuclear lamina consist of a two-dimensional matri...

Pending

RbAp48 protein

Histone-binding protein RBBP4 (also known as RbAp48, or NURF55) is a protein that in humans is encoded by the RBBP4 gene. This gene encodes a ubiquitously expressed nuclear protein that belongs to...

Granted

NGAL/Kidney disease

n the case of acute kidney injury (AKI), NGAL is secreted in high levels into the blood and urine within 2 hours of injury.[9] Because NGAL is protease resistant and small, the protein is easily ex...

Granted

Degradable model networks

Degradable model networks

Pending

PHB domain protein activity...

PHB domain protein activity modulation

Granted

Detecting anomalous program...

Detecting anomalous program executions

Pending

RNA

Ribonucleic acid (RNA) is a polymeric molecule. It is implicated in various biological roles in coding, decoding, regulation, and expression of genes. DNA and RNA are nucleic acids, and, along with...

Granted

Fluorescent nucleotides

Fluorescent nucleotides

Pending

Securing communications bet...

Securing communications between nodes

Granted

Nucleotide analogue

Nucleotide analogue

  • First
  • Prev
  • …
  • 781
  • 782
  • 783
  • 784
  • 785
  • 786
  • 787
  • 788
  • 789
  • …
  • Next
  • Last
Your one-stop shop for innovation and intellectual property Join us today

About us

IP Nexus is an IP commercialisation company that builds successful startup companies by collaborating with inventors, universities and research institutes to identify high-potential inventions at an early stage and provide the commercial direction, fundraising expertise and management talent necessary to build outstanding companies. IP Nexus has particular focus and expertise in Asia.

Disclaimer

IP Nexus, including the Ask an Expert and Services Marketplace, is an interactive online service that makes it faster and easier for businesses to find and hire legal help solely based on their search preferences. We are not a law firm, do not provide any legal services, legal advice or lawyer referral services and do not provide or participate in any legal representation.

Content

  • PRICING
  • FREQUENTLY ASKED QUESTIONS
  • IP PROTECTION
  • IP TYPES
  • IP CLAIMS
  • OUR TEAM
  • STARTUPS
  • CONTACT US
  • BRAND ASSETS
  • TERM OF USE
  • PRIVACY POLICY
  • SEARCH PATENTS ON PATENTFIELD

Newsletter

Subscribe

Languages

Icon jp

Logo gray © 2025 IP Nexus. All Rights Reserved.

Report content

      Contact form